Human Plasma Lipoprotein Metabolism

[1]  J. B. Massey,et al.  Serum opacity factor unmasks human plasma high-density lipoprotein instability via selective delipidation and apolipoprotein A-I desorption. , 2007, Biochemistry.

[2]  C. Stathopoulos,et al.  Molecular cloning and biochemical characterization of VIM-12, a novel hybrid VIM-1/VIM-2 metallo-beta-lactamase from a Klebsiella pneumoniae clinical isolate, reveal atypical substrate specificity. , 2007, Biochemistry.

[3]  W. März,et al.  Beyond HDL-cholesterol increase: phospholipid enrichment and shift from HDL3 to HDL2 in alcohol consumers Published, JLR Papers in Press, April 12, 2007. , 2007, Journal of Lipid Research.

[4]  J. B. Massey,et al.  Speciation of human plasma high-density lipoprotein (HDL): HDL stability and apolipoprotein A-I partitioning. , 2007, Biochemistry.

[5]  U. Smith,et al.  Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer? , 2007, Diabetologia.

[6]  M. Jauhiainen,et al.  Macrophage Phospholipid Transfer Protein Contributes Significantly to Total Plasma Phospholipid Transfer Activity and Its Deficiency Leads to Diminished Atherosclerotic Lesion Development , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[7]  C. Devlin,et al.  Macrophage Phospholipid Transfer Protein Deficiency and ApoE Secretion: Impact on Mouse Plasma Cholesterol Levels and Atherosclerosis , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[8]  H. Pownall.  Detergent-mediated phospholipidation of plasma lipoproteins increases HDL cholesterophilicity and cholesterol efflux via SR-BI. , 2006, Biochemistry.

[9]  L. Lagrost,et al.  Atheroprotective Potential of Macrophage-Derived Phospholipid Transfer Protein in Low-Density Lipoprotein Receptor–Deficient Mice Is Overcome by Apolipoprotein AI Overexpression , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[10]  F. Kronenberg,et al.  The ATGL Gene Is Associated With Free Fatty Acids, Triglycerides, and Type 2 Diabetes , 2006, Diabetes.

[11]  C. Rock,et al.  Serum Opacity Factor, a Streptococcal Virulence Factor That Binds to Apolipoproteins A-I and A-II and Disrupts High Density Lipoprotein Structure* , 2006, Journal of Biological Chemistry.

[12]  John A Spertus,et al.  Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Executive Summary , 2005, Critical pathways in cardiology.

[13]  H. Pownall.  Remodeling of human plasma lipoproteins by detergent perturbation. , 2005, Biochemistry.

[14]  P. Mohler,et al.  Microsomal triglyceride transfer protein expression in adipocytes: A new component in fat metabolism , 2005, FEBS letters.

[15]  O. Gursky.  Apolipoprotein structure and dynamics , 2005, Current opinion in lipidology.

[16]  Frank Eisenhaber,et al.  Fat Mobilization in Adipose Tissue Is Promoted by Adipose Triglyceride Lipase , 2004, Science.

[17]  P. Edwards,et al.  Expression and Regulation of Multiple Murine ATP-binding Cassette Transporter G1 mRNAs/Isoforms That Stimulate Cellular Cholesterol Efflux to High Density Lipoprotein* , 2004, Journal of Biological Chemistry.

[18]  Vidya Subramanian,et al.  Perilipin A Mediates the Reversible Binding of CGI-58 to Lipid Droplets in 3T3-L1 Adipocytes* , 2004, Journal of Biological Chemistry.

[19]  A. Garg.  Regional adiposity and insulin resistance. , 2004, The Journal of clinical endocrinology and metabolism.

[20]  P. Saha,et al.  Metabolic Adaptations in the Absence of Perilipin , 2004, Journal of Biological Chemistry.

[21]  T. Osumi,et al.  CGI-58 Interacts with Perilipin and Is Localized to Lipid Droplets , 2004, Journal of Biological Chemistry.

[22]  A. Tall,et al.  ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[23]  T. Okura,et al.  Regional Body Composition Changes Exhibit Opposing Effects on Coronary Heart Disease Risk Factors , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[24]  I. Lemieux.  Energy partitioning in gluteal-femoral fat: does the metabolic fate of triglycerides affect coronary heart disease risk? , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[25]  Y. Yamauchi,et al.  Potential involvement of dissociated apoA-I in the ABCA1-dependent cellular lipid release by HDL Published, JLR Papers in Press, January 16, 2004. DOI 10.1194/jlr.M300257-JLR200 , 2004, Journal of Lipid Research.

[26]  H. Pownall,et al.  Pathophysiology of dyslipidemia and increased cardiovascular risk in HIV lipodystrophy: a model of ‘systemic steatosis’ , 2004, Current opinion in lipidology.

[27]  W. Chiu,et al.  Structure of triglyceride-rich human low-density lipoproteins according to cryoelectron microscopy. , 2003, Biochemistry.

[28]  Paul Schoenhagen,et al.  Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. , 2003, JAMA.

[29]  M. Jensen,et al.  Effects of pioglitazone versus diet and exercise on metabolic health and fat distribution in upper body obesity. , 2003, Diabetes care.

[30]  Fernando Castro-Chavez,et al.  Coordinated upregulation of oxidative pathways and downregulation of lipid biosynthesis underlie obesity resistance in perilipin knockout mice: a microarray gene expression profile. , 2003, Diabetes.

[31]  L. Lagrost,et al.  Increased Atherosclerotic Lesions in ApoE Mice With Plasma Phospholipid Transfer Protein Overexpression , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[32]  Anoop Misra,et al.  Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots. , 2003, Nutrition.

[33]  P. Yancey,et al.  Importance of different pathways of cellular cholesterol efflux. , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[34]  D. Gantz,et al.  Human plasma high-density lipoproteins are stabilized by kinetic factors. , 2003, Journal of molecular biology.

[35]  H. Lebovitz.  The relationship of obesity to the metabolic syndrome. , 2003, International journal of clinical practice. Supplement.

[36]  R. Huupponen,et al.  Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects. , 2003, Diabetes.

[37]  B. Litman,et al.  Determination of membrane cholesterol partition coefficient using a lipid vesicle-cyclodextrin binary system: effect of phospholipid acyl chain unsaturation and headgroup composition. , 2002, Biophysical journal.

[38]  H. Pownall,et al.  Metabolic basis of HIV-lipodystrophy syndrome. , 2002, American journal of physiology. Endocrinology and metabolism.

[39]  J. Parks,et al.  Lecithin:Cholesterol Acyltransferase Deficiency Increases Atherosclerosis in the Low Density Lipoprotein Receptor and Apolipoprotein E Knockout Mice* , 2002, The Journal of Biological Chemistry.

[40]  J. McGarry.  Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. , 2002, Diabetes.

[41]  G. S. Shelness,et al.  ApoA-I secretion from HepG2 cells: evidence for the secretion of both lipid-poor apoA-I and intracellularly assembled nascent HDL. , 2002, Journal of lipid research.

[42]  C. Fielding,et al.  Cellular cholesterol efflux. , 2001, Biochimica et biophysica acta.

[43]  S. Lorkowski,et al.  The human ABCG4 gene is regulated by oxysterols and retinoids in monocyte-derived macrophages. , 2001, Biochemical and biophysical research communications.

[44]  Jonathan C. Cohen,et al.  An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing , 2001, Science.

[45]  F. Semeria,et al.  Intravenous apoA-I/lecithin discs increase pre-beta-HDL concentration in tissue fluid and stimulate reverse cholesterol transport in humans. , 2001, Journal of lipid research.

[46]  M. Jauhiainen,et al.  The Mechanism of the Remodeling of High Density Lipoproteins by Phospholipid Transfer Protein* , 2001, The Journal of Biological Chemistry.

[47]  J. Brady,et al.  Analysis of Glomerulosclerosis and Atherosclerosis in Lecithin Cholesterol Acyltransferase-deficient Mice* , 2001, The Journal of Biological Chemistry.

[48]  J. Després,et al.  Health consequences of visceral obesity , 2001, Annals of medicine.

[49]  D. Gorenstein,et al.  Absence of perilipin results in leanness and reverses obesity in Leprdb/db mice , 2000, Nature Genetics.

[50]  B. Wajchenberg.  Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. , 2000, Endocrine reviews.

[51]  W. J. Johnson,et al.  High Density Lipoprotein Phospholipid Composition Is a Major Determinant of the Bi-directional Flux and Net Movement of Cellular Free Cholesterol Mediated by Scavenger Receptor BI* , 2000, The Journal of Biological Chemistry.

[52]  N. Barzilai,et al.  The regulation of body fat distribution and the modulation of insulin action , 2000, International Journal of Obesity.

[53]  E. Fisher,et al.  The Amino-terminal Domain of Apolipoprotein B Does Not Undergo Retrograde Translocation from the Endoplasmic Reticulum to the Cytosol , 2000, The Journal of Biological Chemistry.

[54]  K. Frayn.  Visceral fat and insulin resistance — causative or correlative? , 2000, British Journal of Nutrition.

[55]  H. Prydz,et al.  Overexpression of human lecithin:cholesterol acyltransferase in mice offers no protection against diet‐induced atherosclerosis Note , 2000, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[56]  D L Rothman,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Intramuscular Glycogen and Intramyocellular Lipid Utilization during Prolonged Exercise and Recovery in Man: A 13 C and 1 H Nuclear Magnetic Res , 1999 .

[57]  A. Tall,et al.  Hepatic Scavenger Receptor BI Promotes Rapid Clearance of High Density Lipoprotein Free Cholesterol and Its Transport into Bile* , 1999, The Journal of Biological Chemistry.

[58]  W. Chiu,et al.  Three-dimensional structure of low density lipoproteins by electron cryomicroscopy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[59]  C. Ballantyne,et al.  Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins. , 1999, Atherosclerosis.

[60]  P. Lerch,et al.  Acute effects of intravenous infusion of ApoA1/phosphatidylcholine discs on plasma lipoproteins in humans. , 1999, Arteriosclerosis, Thrombosis and Vascular Biology.

[61]  E. Rubin,et al.  Lower Plasma Levels and Accelerated Clearance of High Density Lipoprotein (HDL) and Non-HDL Cholesterol in Scavenger Receptor Class B Type I Transgenic Mice* , 1999, The Journal of Biological Chemistry.

[62]  J. Borén,et al.  Assembly of very low density lipoprotein: a two-step process of apolipoprotein B core lipidation. , 1999, The Journal of nutrition.

[63]  K. Weisgraber,et al.  Apolipoprotein-mediated Plasma Membrane Microsolubilization , 1999, The Journal of Biological Chemistry.

[64]  L. DiPietro,et al.  Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study , 1999, Diabetologia.

[65]  A. Tall,et al.  Liver-specific Overexpression of Scavenger Receptor BI Decreases Levels of Very Low Density Lipoprotein ApoB, Low Density Lipoprotein ApoB, and High Density Lipoprotein in Transgenic Mice* , 1998, The Journal of Biological Chemistry.

[66]  E. Fisher,et al.  Regulated Co-translational Ubiquitination of Apolipoprotein B100 , 1998, The Journal of Biological Chemistry.

[67]  A. Tall,et al.  Biliary cholesterol excretion: a novel mechanism that regulates dietary cholesterol absorption. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[68]  J. Patsch.  Influence of lipolysis on chylomicron clearance and HDL cholesterol levels. , 1998, European heart journal.

[69]  K. V. van Dijk,et al.  Adenovirus mediated overexpression of human phospholipid transfer protein alters plasma HDL levels in mice. , 1998, Journal of lipid research.

[70]  A. Tall,et al.  Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[71]  W. J. Johnson,et al.  Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes. , 1998, Atherosclerosis.

[72]  G. Anantharamaiah,et al.  Removal of cellular cholesterol by pre-beta-HDL involves plasma membrane microsolubilization. , 1997, Journal of lipid research.

[73]  Alan D. Lopez,et al.  Alcohol consumption and mortality among middle-aged and elderly U.S. adults. , 1997, The New England journal of medicine.

[74]  L. Solberg,et al.  Mice overexpressing human lecithin: cholesterol acvltransferase are not protected against diet‐induced atherosclerosis , 1997, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[75]  R. F. Hoyt,et al.  High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithinchoesteryl acyltransferase , 1997, Nature Medicine.

[76]  E. Edelman,et al.  Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels , 1997, Nature.

[77]  O. Francone,et al.  Modification of the cholesterol efflux properties of human serum by enrichment with phospholipid. , 1997, Journal of lipid research.

[78]  H. Pownall,et al.  Molecular and macromolecular specificity of human plasma phospholipid transfer protein. , 1997, Biochemistry.

[79]  R M Peshock,et al.  Relationship of anterior and posterior subcutaneous abdominal fat to insulin sensitivity in nondiabetic men. , 1997, Obesity research.

[80]  P. Barter,et al.  Evidence That Cholesteryl Ester Transfer Protein-mediated Reductions in Reconstituted High Density Lipoprotein Size Involve Particle Fusion* , 1997, The Journal of Biological Chemistry.

[81]  P. Barter,et al.  Remodelling of reconstituted high density lipoproteins by lecithin: cholesterol acyltransferase. , 1996, Journal of lipid research.

[82]  A. Tall,et al.  Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. , 1996, The Journal of clinical investigation.

[83]  Helen H. Hobbs,et al.  Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor , 1996, Science.

[84]  R. Hammer,et al.  Mutagenesis of the human apolipoprotein B gene in a yeast artificial chromosome reveals the site of attachment for apolipoprotein(a). , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[85]  S. Grundy,et al.  Relationships of generalized and regional adiposity to insulin sensitivity in men. , 1995, The Journal of clinical investigation.

[86]  G. Francis,et al.  Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. , 1995, The Journal of clinical investigation.

[87]  S. Qu,et al.  In vitro expression of natural mutants of human lecithin:cholesterol acyltransferase. , 1995, Journal of lipid research.

[88]  W. J. Johnson,et al.  The Effect of High Density Lipoprotein Phospholipid Acyl Chain Composition on the Efflux of Cellular Free Cholesterol (*) , 1995, The Journal of Biological Chemistry.

[89]  P. Ducimetiere,et al.  Upper-body fat distribution: a hyperinsulinemia-independent predictor of coronary heart disease mortality. The Paris Prospective Study. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[90]  D. Rader,et al.  Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. , 1992, Science.

[91]  Henry N. Ginsberg,et al.  Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles. , 1992, The Journal of clinical investigation.

[92]  J. McGarry,et al.  What if Minkowski had been ageusic? An alternative angle on diabetes. , 1992, Science.

[93]  H. Brewer,et al.  Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C‐II , 1992, Journal of internal medicine.

[94]  H. Ginsberg,et al.  Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B. , 1991, The Journal of biological chemistry.

[95]  R. Havel,et al.  Isolation and properties of nascent lipoproteins from highly purified rat hepatocytic Golgi fractions. , 1991, Journal of lipid research.

[96]  S. Yokoyama,et al.  Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. , 1991, The Journal of biological chemistry.

[97]  J. Breslow,et al.  Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. , 1990, Science.

[98]  R. Hoffmann,et al.  Adiposity, fat distribution, and cardiovascular risk. , 1989, Annals of internal medicine.

[99]  I. Goldberg,et al.  Release of endothelial cell lipoprotein lipase by plasma lipoproteins and free fatty acids. , 1989, The Journal of biological chemistry.

[100]  A. Kissebah,et al.  Relationship of anthropometric measurements of body fat distribution to metabolic profile in premenopausal women. , 2009, Acta medica Scandinavica. Supplementum.

[101]  R. Mueller,et al.  Glucose metabolism in obesity: influence of body fat distribution. , 1988, The Journal of clinical endocrinology and metabolism.

[102]  J. Huttunen,et al.  Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. , 1988, JAMA.

[103]  L. McLean,et al.  Influence of molecular packing and phospholipid type on rates of cholesterol exchange. , 1986, Biochemistry.

[104]  A A Rimm,et al.  A weight shape index for assessing risk of disease in 44,820 women. , 1988, Journal of clinical epidemiology.

[105]  Z W Gu,et al.  Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. , 1987, Science.

[106]  R. Pease,et al.  A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine , 1987, Cell.

[107]  W. J. Johnson,et al.  Mechanisms and consequences of cellular cholesterol exchange and transfer. , 1987, Biochimica et biophysica acta.

[108]  D. Reed,et al.  CENTRAL OBESITY AND CORONARY HEART DISEASE IN MEN , 1987, The Lancet.

[109]  Y. Matsuzawa,et al.  Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. , 1987, Metabolism: clinical and experimental.

[110]  J. B. Massey,et al.  Partially Reassembled High Density Lipoproteins: Effects on Cholesterol Flux, Synthesis, and Esterification in Normal Human Skin Fibroblasts , 1986, Arteriosclerosis.

[111]  W. J. Johnson,et al.  The bidirectional flux of cholesterol between cells and lipoproteins. Effects of phospholipid depletion of high density lipoprotein. , 1986, The Journal of biological chemistry.

[112]  T. Forte,et al.  Characterization of lipoproteins produced by the human liver cell line, Hep G2, under defined conditions. , 1986, Journal of lipid research.

[113]  F. Cambien,et al.  The pattern of subcutaneous fat distribution in middle-aged men and the risk of coronary heart disease: the Paris Prospective Study. , 1986, International journal of obesity.

[114]  P. Björntorp,et al.  The Influence of Body Fat Distribution on the Incidence of Diabetes Mellitus: 13.5 Years of Follow-up of the Participants in the Study of Men Born in 1913 , 1985, Diabetes.

[115]  K. Pennert,et al.  Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. , 1984, British medical journal.

[116]  A. Gotto,et al.  Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[117]  A. Gotto,et al.  Action of lecithin:cholesterol acyltransferase on model lipoproteins. Preparation and characterization of model nascent high density lipoprotein. , 1982, Biochimica et biophysica acta.

[118]  R. Mahley,et al.  Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[119]  J. Albers,et al.  Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin: cholesterol acyltransferase activity. , 1982, Journal of lipid research.

[120]  A. Jonas,et al.  Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. , 1982, The Journal of biological chemistry.

[121]  A. Jonas,et al.  Reaction of human lecithin cholesterol acyltransferase with synthetic micellar complexes of apolipoprotein A-I, phosphatidylcholine, and cholesterol. , 1982, Journal of Biological Chemistry.

[122]  A. Kissebah,et al.  Relation of Body Fat Distribution to Metabolic Complications of Obesity , 1982 .

[123]  R. Mahley,et al.  Rapid hepatic clearance of the canine lipoproteins containing only the E apoprotein by a high affinity receptor. Identity with the chylomicron remnant transport process. , 1980, The Journal of biological chemistry.

[124]  A. Tall,et al.  Plasma high-density lipoproteins. , 1978, The New England journal of medicine.

[125]  A. Gotto,et al.  Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[126]  E. Gong,et al.  Effects of guanidine hydrochloride on human plasma high density lipoproteins. , 1976, Biochimica et biophysica acta.

[127]  R L Jackson,et al.  Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase. , 1975, Biochemistry.

[128]  G. Utermann,et al.  Familial hyperlipoproteinemia type III: Deficiency of a specific apolipoprotein (APO E‐III) in the very‐low‐density lipoproteins , 1975, FEBS letters.

[129]  C. Fielding,et al.  A protein cofactor of lecithin:cholesterol acyltransferase. , 1972, Biochemical and biophysical research communications.

[130]  J. Larosa,et al.  A specific apoprotein activator for lipoprotein lipase. , 1970, Biochemical and biophysical research communications.

[131]  R. Havel,et al.  Role of Specific Glycopeptides of Human Serum Lipoproteins in the Activation of Lipoprotein Lipase , 1970, Circulation research.

[132]  J. Glomset,et al.  The plasma lecithins:cholesterol acyltransferase reaction. , 1968, Journal of lipid research.

[133]  F. Parker,et al.  The esterification in vitro of free cholesterol in human and rat plasma. , 1962, Biochimica et biophysica acta.

[134]  J. Vague,et al.  The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. , 1956, The American journal of clinical nutrition.

[135]  E. Korn.  Properties of clearing factor obtained from rat heart acetone powder. , 1954, Science.

[136]  J. Vague.  Sexual differentiation; Factor determining forms of obesity. , 1947 .

[137]  P. Hahn.  ABOLISHMENT OF ALIMENTARY LIPEMIA FOLLOWING INJECTION OF HEPARIN. , 1943, Science.

[138]  W. Sperry.  CHOLESTEROL ESTERASE IN BLOOD , 1935 .